SAMSONITE (01910) grants restricted stock units and long-term cash incentives.
Samsonite (01910) announced that on June 9, 2026, the company granted 2.0722 million restricted stock units and 2.6154 million restricted stock units tied to a special one-time occasion to Mr. Gendreau under the stock award plan. In addition, the company also granted 2.9053 million restricted stock units and 2.1045 million restricted stock units tied to a special one-time occasion to several other senior executives, subject to their acceptance.
SAMSONITE (01910) announced that on June 9, 2026, the company granted Mr. Gendreau 2.0722 million restricted stock units and 2.6154 million restricted stock units linked to a special one-time guarantee. In addition, several other senior management personnel were granted 2.9053 million restricted stock units and 2.1045 million restricted stock units linked to a special one-time guarantee, subject to acceptance by the grantee.
The company also granted long-term cash bonus opportunities to several employees of the group. The long-term cash bonus entitles the grantee to receive a target cash amount in three equal installments over a three-year period. The purpose of the long-term cash bonus is to retain the grantee by ensuring that the bonus will be vested over a period of time and the payment of the target amount is guaranteed. Furthermore, to incentivize future performance, if the share price increases during the three-year vesting period, the long-term cash bonus allows the grantee to share in the benefits of business growth. If certain share price targets are met, the amount payable to the grantee under the long-term cash bonus may increase (up to 150% of the target amount). Using the long-term cash bonus to replace additional grants under the stock reward plan provides the company with the opportunity to offer long-term incentives to key employees of the group while managing the dilution of equity resulting from all rewards granted under the stock reward plan in 2026.
Related Articles

HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.

NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.

WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.

NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.

WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.

RECOMMEND





